At the time of writing, Sonoma Pharmaceuticals Inc [SNOA] stock is trading at $3.86, up 9.35%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The SNOA shares have gain 38.35% over the last week, with a monthly amount glided 47.33%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
For the past year, the stock price of Sonoma Pharmaceuticals Inc fluctuated between $1.90 and $9.37. Sonoma Pharmaceuticals Inc [NASDAQ: SNOA] shares were valued at $3.86 at the most recent close of the market.
Analyzing the SNOA fundamentals
According to Sonoma Pharmaceuticals Inc [NASDAQ:SNOA], the company’s sales were 13.97M for trailing twelve months, which represents an 13.58% jump. Gross Profit Margin for this corporation currently stands at 0.36% with Operating Profit Margin at -0.32%, Pretax Profit Margin comes in at -0.27%, and Net Profit Margin reading is -0.27%. To continue investigating profitability, this company’s Return on Assets is posted at -0.27, Equity is -0.7 and Total Capital is -0.45. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.72 points at the first support level, and at 3.58 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.04, and for the 2nd resistance point, it is at 4.22.
Ratios To Look Out For
It is important to note that Sonoma Pharmaceuticals Inc [NASDAQ:SNOA] has a current ratio of 3.29. In addition, the Quick Ratio stands at 2.44 and the Cash Ratio stands at 1.41. Considering the valuation of this stock, the price to sales ratio is 0.45, the price to book ratio is 1.28.
Transactions by insiders
Recent insider trading involved Gottfurcht Grant, 10% Owner, that happened on Jan 03 ’25 when 86111.0 shares were purchased. Open Market, Gottfurcht Grant completed a deal on Jan 02 ’25 to buy 30000.0 shares. Meanwhile, Open Market Purchase Gottfurcht Grant bought 17806.0 shares on Dec 31 ’24.
